**FOR IMMEDIATE RELEASE**

FOR IMMEDIATE RELEASE

TRUMPRX: UNAUTHORIZED MEDICAL PRODUCT FEATURING FORMER PRESIDENT’S NAME SPARKS FDA INQUIRY

WASHINGTON, D.C. – November 1, 2023 (11:00 AM EST)

What: An unauthorized, unregulated medical product marketed under the name “TrumpRx” has been identified for sale via unlicensed online retailers. Preliminary investigations confirm the product, described as a broad-spectrum “immunity booster,” contains unapproved, unlisted active ingredients and makes claims of preventing respiratory illness without clinical evidence. The product is not affiliated with any official Trump Organization entity or the former President.

Who: The U.S. Food and Drug Administration (FDA) has launched a formal inquiry into the manufacturing and distribution source. The former President’s legal representatives have issued a cease-and-desist letter to the alleged distributors. Consumer advocacy groups are warning the public against purchase.

When: The product listing appeared on at least three high-traffic e-commerce platforms and two subscription-based health supplement websites within the last thirty days. The FDA began its investigation five days ago following reports of adverse reactions from at least four individuals.

Where: The product’s manufacturing location is currently unknown, with initial tracking indicating a non-compliant facility registered in the Caribbean. Distribution is traced to a network of third-party logistics centers in Texas, Florida, and Ohio. The product was primarily marketed to consumers in rural “MAGA-heavy” districts.

Why: The FDA states the investigation is a matter of public health safety, citing potential contamination and dangerous ingredient masking. Furthermore, legal action is anticipated regarding the unauthorized use of a protected public figure’s name and likeness for medical claims.

Source: Official statement from the FDA Press Office; Legal filing from Trump Organization Counsel.